Top Markets
Coin of the day
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc.

OTLC
Pozycja w akcjach #30395
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage... Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
Cena akcji
$0.03834
Ostatnia synchronizacja: 2026-08-18
Kapitalizacja rynkowa
$17.01M
Zmiana (1 dzień)
-4.15%
Zmiana (1 rok)
-24.82%
Kraj
US
Handel Oncotelic Therapeutics, Inc. (OTLC)

Kategoria

Historia stopy dywidendy dla Oncotelic Therapeutics, Inc. (OTLC)
Stopa dywidendy (TTM) dla Oncotelic Therapeutics, Inc. (symbol akcji: OTLC) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Oncotelic Therapeutics, Inc. (OTLC) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE